Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
gm6001 | matrix metalloproteinase-1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Corneal Ulcer[MeSHID:D003320] |
NA | discontinued in phase 2 | unknown |
gm6001 | matrix metalloproteinase-12 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Corneal Ulcer[MeSHID:D003320] |
NA | discontinued in phase 2 | unknown |
gm6001 | matrix metalloproteinase-13 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Corneal Ulcer[MeSHID:D003320] |
NA | discontinued in phase 2 | unknown |
gm6001 | matrix metalloproteinase-14 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Corneal Ulcer[MeSHID:D003320] |
NA | discontinued in phase 2 | unknown |
gm6001 | matrix metalloproteinase-2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Corneal Ulcer[MeSHID:D003320] |
NA | discontinued in phase 2 | unknown |
gm6001 | matrix metalloproteinase-3 | NA | Patented-recorded target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Corneal Ulcer[MeSHID:D003320] |
NA | discontinued in phase 2 | unknown |
gm6001 | matrix metalloproteinase-8 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Corneal Ulcer[MeSHID:D003320] |
NA | discontinued in phase 2 | unknown |
gm6001 | matrix metalloproteinase-9 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Corneal Ulcer[MeSHID:D003320] |
NA | discontinued in phase 2 | unknown |
click here to return to the previous page |